Oppositional defiant disorder.
Hamilton SS, Armando J.
Am Fam Physician. 2008 Oct 1;78(7):861-6.
Five-factor personality traits and functional somatic disorder: A systematic review and meta-analysis.
Lamm TT, Von Schrottenberg V, Rauch A, Bach B, Pedersen HF, Rask MT, Ørnbøl E, Wellnitz KB, Frostholm L.
Clin Psychol Rev. 2025 Feb;115:102529. doi: 10.1016/j.cpr.2024.102529. Epub 2024 Dec 12.
The relationship between self-reported borderline personality features and prospective illness course in bipolar disorder.
Riemann G, Weisscher N, Post RM, Altshuler L, McElroy S, Frye MA, Keck PE Jr, Leverich GS, Suppes T, Grunze H, Nolen WA, Kupka RW.
Int J Bipolar Disord. 2017 Sep 25;5(1):31. doi: 10.1186/s40345-017-0100-x.
Neuropsychiatric Adverse Effects of Amphetamine and Methamphetamine.
Harro J.
Int Rev Neurobiol. 2015;120:179-204. doi: 10.1016/bs.irn.2015.02.004. Epub 2015 Mar 12.
Psychopathology and psychological problems in patients with burn scars: epidemiology and management.
Van Loey NE, Van Son MJ.
Am J Clin Dermatol. 2003;4(4):245-72. doi: 10.2165/00128071-200304040-00004.
[Pharmacological treatment of borderline personality disorder].
Mazaira S.
Vertex. 2004 Dec-2005 Feb;15(58):303-8.
Personality disorders in primary care.
Paré MF, Rosenbluth M.
Prim Care. 1999 Jun;26(2):243-78. doi: 10.1016/s0095-4543(08)70005-8.
Healing the caregiver.
Milstein JM, Gerstenberger AE, Barton S.
J Altern Complement Med. 2002 Dec;8(6):917-20. doi: 10.1089/10755530260511919.
CANFOR Portuguese version: validation study.
Talina M, Thomas S, Cardoso A, Aguiar P, Caldas de Almeida JM, Xavier M.
BMC Psychiatry. 2013 May 30;13:157. doi: 10.1186/1471-244X-13-157.
Pharmacotherapy and psychotherapy in depression - complementarity or exclusion?
Mosiołek A, Podlecka M.
Postep Psychiatr Neurol. 2024 Dec;33(4):257-266. doi: 10.5114/ppn.2024.147104. Epub 2025 Feb 25.
